An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer

BackgroundThis open, observational clinical study aimed to investigate the efficacy, safety and survival outcomes of neoadjuvant chemotherapy, neoadjuvant immunotherapy with(out) chemotherapy and neoadjuvant targeted therapy among resectable stage III non-small cell lung cancer (NSCLC) patients (NCT...

Full description

Bibliographic Details
Main Authors: Yuwen Qi, Linping Gu, Jie Shen, Yaxian Yao, Yi Zhao, Shun Lu, Zhiwei Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Oncology
Subjects:
resectable stage III NSCLC
neoadjuvant therapy
disease-free survival
pathological complete response
clinical trial
adverse events
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1194100/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1194100/full

Similar Items